USP water systems
Ran a purified water system day to day, led the redesign of a generation and distribution loop, and qualified it under GMP.
- 21 CFR 211.48
- BCC & objectionable organisms
- Microbial recalls
FDA Watch · for CPG manufacturers
What FDA is finding in consumer products right now.
Recall root causes, inspection observations, and warning letters across OTC drugs, food and beverage, and cosmetics, read by an operator who has run FDA-inspected consumer products manufacturing for two decades.
Curated by Kobe Ofori-atta
20 years in FDA-regulated consumer products manufacturing · Zero major FDA audit findings · About Kobe
Featured · USP Water Watch
Water is the first ingredient in most consumer products, and where contamination often starts.
FDA has warned that deficient practices, particularly in the design, control, and maintenance of water systems
, have led to contamination with Burkholderia cepacia complex (BCC) and other water-borne organisms in non-sterile, water-based products. Read FDA’s advisory.
Recent recalls naming water-borne organisms
- Loading FDA data…
Form 483 water-system observations
By category
Where consumer products are failing, and why.
What’s driving recalls
Recall events by root cause, last 12 months
Recalls by month
Recall events reported to FDA, last 12 months
Most-cited inspection observations
Form 483 observations cited most often in the last 12 months, each mapped to the operating capability that prevents it.
Latest recalls
From FDA enforcement reports. Class I is the most serious.
Recent warning letters
Issued in the last 12 months, most recent first.
Latest inspection findings
Recently closed inspections with at least one Form 483 observation.
FDA data is temporarily unavailable. You can browse it directly in FDA’s Enforcement Report and on the FDA Data Dashboard.
Read by an operator
The failures above are operating problems. These are the operating fixes.
Validation & qualification
Led qualification and validation of HVAC, clean utilities, and process equipment within more than $25M in capital programs.
- Process validation
- Equipment qualification
- 21 CFR 211.100
Audit readiness & CAPA
Planned and executed FDA, GMP, and ISO 9001 audits and drove corrective action, with zero major FDA audit findings.
- Investigations (211.192)
- CAPA (820.100)
- Quality unit
Supplier quality
Ran supplier qualification, capability audits, scorecards, and dual-sourcing for raw materials and packaging.
- Component testing (211.84)
- Supplier controls
- Foreign material
Stability & scale-up
Ran stability lab operations and moved products from pilot to commercial manufacturing three times faster.
- Stability (211.166)
- Specifications
- Potency recalls
Reliability & maintenance
Directed preventive and autonomous maintenance programs for GMP manufacturing equipment.
- Equipment cleaning (211.67)
- Sanitation
- Downtime
Inspection on the horizon?
The most-cited observations are the most preventable.
Claraxis helps consumer products manufacturers find and close these gaps before an investigator does, while keeping production running.
About this data
Sources: openFDA enforcement reports (recalls), the FDA Data Dashboard (Form 483 observations and warning letters), and FDA’s advisory on BCC in water-based products. These are public U.S. government records, refreshed here several times a day. FDA publishes them on its own schedule, so recent activity may take weeks to appear.
Product categories and root causes are assigned by Claraxis from FDA’s product descriptions and recall reasons, and counts are of recall events rather than individual products. The water-system checklist reflects common FDA expectations and is not a complete compliance standard. Firms are listed only because they appear in FDA’s public records. Listing does not imply any relationship with Claraxis Group, and no firm shown is presented as a Claraxis client. A Form 483 observation is an investigator’s observation, not a final agency determination. Claraxis Group is not affiliated with the U.S. Food and Drug Administration. This page is general information, not regulatory or legal advice.